The current results together with previous data reporting a role of DEPDC1A in promoting epithelial cancer proliferation suggest that DEPDC1A could be an interesting target in multiple myeloma, with potentially limited toxicity. The gene discussed is DEPDC1; the disease is plasma cell myeloma.